WilmerHale Advises Thermo Fisher on $2.5 Billion Offering of Senior Notes

WilmerHale Advises Thermo Fisher on $2.5 Billion Offering of Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.

WilmerHale advised Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) in connection with its offering of $500,000,000 aggregate principal amount of its 4.200% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 4.473% Senior Notes due 2032, $750,000,000 aggregate principal amount of its 4.794% Senior Notes due 2035 and $500,000,000 aggregate principal amount of its 4.894% Senior Notes due 2037. The offering priced on September 30, 2025, and closed on October 7, 2025. The joint book-running managers for the offering were J.P. Morgan Securities LLC, ING Financial Markets LLC, Mizuho Securities USA LLC and Scotia Capital (USA) Inc.

The WilmerHale team advising Thermo Fisher on the offering consisted of Molly Fox, Andrew Langworthy, Katharine Patterson, and Tim Kolankowski (Capital Markets), with assistance from Meghan Walsh and Ben Kelsey (Tax).

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel